Cancer is a scary word -- pancreatic cancer is beyond scary. It has one of the highest mortality rates of all cancers. Symptoms of the disease usually are hard to recognize and most patients are diagnosed in the advanced stages.
Anytime I read about a new drug that can increase the survival of this deadly disease I get excited. An early online publication of the Journal of Clinical Oncology states that the addition to the targeted agent Tarceva (erlotinib) to Gemzar (gemcitabine) can improve survival in patients diagnosed with advanced pancreatic cancer.
The Phase III clinical trial included 569 patients who were either treated with Tarceva plus Gemzar or Gemzar plus placebo. At one year the survival of those treated with the drug combination reached 23 percent. Gemzar alone had a 17 percent survival rate at one year. The study also said that more patients treated with the combination of Tarceva/Gemzar achieved stabilization of their disease.
I am hoping that sooner, rather than later this disease will not be beyond scary and will be something that can be treated, controlled and one day cured.
1. The remarkable advances in cancer treatments and research are often overlooked, and this is a great example of a breakthrough that could make a lot of waves.
Here's a link to a video that really clarifies the progress being made: http://www.cancer.ca/ccs/internet/standard/0,3182,3278_316992_1900716089__langId-en,00.html
Posted at 3:20PM on May 3rd 2007 by ForTheCure